"A personalized limited sampling approach to better estimate terminal half-life of FVIII concentrates": Comment from Huang et al.

被引:0
作者
Huang, Kun [1 ]
Chen, Zhenping [2 ]
Wu, Runhui [1 ]
机构
[1] Capital Med Univ, Natl Ctr Childrens Hlth, Beijing Childrens Hosp, Hematol Ctr, Nanlishi Rd 56, Beijing 100045, Peoples R China
[2] Capital Med Univ, Natl Ctr Childrens Hlth, Beijing Childrens Hosp, Hematol Dis Lab,Beijing Pediat Res Inst, Nanlishi Rd 56, Beijing 100045, Peoples R China
关键词
RECOMBINANT FACTOR-VIII; MODERATE;
D O I
10.1111/jth.15833
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2444 / 2445
页数:2
相关论文
共 10 条
[1]   A personalized limited sampling approach to better estimate terminal half-life of FVIII concentrates [J].
Chelle, Pierre ;
Iorio, Alfonso ;
Edginton, Andrea N. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (09) :2012-2021
[2]   Pharmacokinetic variability of factor VIII concentrates in Chinese pediatric patients with moderate or severe hemophilia A [J].
Chen, Zhenping ;
Huang, Kun ;
Li, Gang ;
Zhen, Yingzi ;
Wu, Xinyi ;
Ai, Di ;
Liu, Guoqing ;
Li, Zekun ;
Alfonso, Iorio ;
Wu, Runhui .
PEDIATRIC INVESTIGATION, 2021, 5 (01) :38-45
[3]   Pharmacokinetic-tailored approach to hemophilia prophylaxis: Medical decision making and outcomes [J].
Croteau, Stacy E. ;
Wheeler, Allison P. ;
Khan, Osman ;
Haley, Kristina M. ;
Borst, Alexandra J. ;
Lattimore, Susan ;
Yeung, Cindy H. T. ;
Iorio, Alfonso .
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (02) :326-333
[4]   Population pharmacokinetic characterization of BAY 81-8973, a full-length recombinant factor VIII: lessons learned - importance of including samples with factor VIII levels below the quantitation limit [J].
Garmann, D. ;
McLeay, S. ;
Shah, A. ;
Vis, P. ;
Enriquez, M. Maas ;
Ploeger, B. A. .
HAEMOPHILIA, 2017, 23 (04) :528-537
[5]   Enhanced pharmacokinetics and reduced bleeds in boys with hemophilia A after switching to Kovaltry from other standard half-life factor VIII concentrates [J].
Huang, Kun ;
Zhen, Yingzi ;
Li, Gang ;
Wu, Xinyi ;
Chen, Zhenping ;
Wu, Runhui .
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (02)
[6]   Inter-individual variability in pharmacokinetics and clinical features in pediatric patients with severe hemophilia A [J].
Huang, Kun ;
Wang, Yan ;
Zhen, Yingzi ;
Li, Gang ;
Wu, Xinyi ;
Zhang, Ningning ;
Chen, Zhenping ;
Wu, Runhui .
THROMBOSIS RESEARCH, 2022, 213 :71-77
[7]   Pharmacokinetic-guided prophylaxis improved clinical outcomes in paediatric patients with severe haemophilia A [J].
Huang, Kun ;
Zhen, Yingzi ;
Li, Gang ;
Wu, Xinyi ;
Chen, Zhenping ;
Wu, Runhui .
HAEMOPHILIA, 2021, 27 (04) :E450-E457
[8]   Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A [J].
Megias-Vericat, J. E. ;
Bonanad, S. ;
Haya, S. ;
Cid, A. R. ;
Marques, M. R. ;
Monte, E. ;
Perez-Alenda, S. ;
Bosch, P. ;
Querol, F. ;
Poveda, J. L. .
THROMBOSIS RESEARCH, 2019, 174 :151-162
[9]   Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH [J].
Ragni, M. V. ;
Croteau, S. E. ;
Morfini, M. ;
Cnossen, M. H. ;
Iorio, A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (07) :1437-1441
[10]   WFH Guidelines for the Management of Hemophilia, 3rd edition [J].
Srivastava, Alok ;
Santagostino, Elena ;
Dougall, Alison ;
Kitchen, Steve ;
Sutherland, Megan ;
Pipe, Steven W. ;
Carcao, Manuel ;
Mahlangu, Johnny ;
Ragni, Margaret V. ;
Windyga, Jerzy ;
Llinas, Adolfo ;
Goddard, Nicholas J. ;
Mohan, Richa ;
Poonnoose, Pradeep M. ;
Feldman, Brian M. ;
Lewis, Sandra Zelman ;
van den Berg, H. Marijke ;
Pierce, Glenn F. .
HAEMOPHILIA, 2020, 26 :1-2